Rude Travel by Vir Sanghvi: A new side of Sri Lanka
Sri Lankans are still hoping for a better future. But in Colombo, its hotels are already prepped for success. And the cuisine ...
Vir Biotech upgraded at Morgan Stanley on cancer drug data
Vir Biotechnology (VIR) stock was upgraded by Morgan Stanley after the company posted trial data for two antitumor agents ...
Rapport Therapeutics, Inc.: Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders
In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted neuroanatomica ...
Johnson & Johnson: Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis
Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...
Fast Drug Launch For Madrigal Pharmaceuticals Brings Buyout Discussion
Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...
Malaysia Sun21h
Nasdaq Composite dips while broader markets close higher
Can you please write a news story about the closing stock market quotes for Wednesday for ALL the following indices but can ...